Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Cancer × Midazolam × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 16 Breast Neoplasms 10 Carcinoma, Non-Small-Cell Lung 9 Melanoma 5 Lung Neoplasms 5 Prostatic Neoplasms 4 Solid Tumor 3 Neoplasm Metastasis 3 Lymphoma, Non-Hodgkin 3 Leukemia, Myeloid, Acute 3 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma 2 Glioma 2 Gastrointestinal Stromal Tumors 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Choledochal Cyst 2 Carcinoma 2 Anxiety Disorders 2 Advanced Solid Tumor 2 Advanced Malignancies 2 cMET-dysregulated Advanced Solid Tumors 1 Urothelial Cancer 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Terminal Cancer 1 Synovitis, Pigmented Villonodular 1 Solid Tumours 1 Solid Tumour 1

Interventions

Nivolumab 15 Surveys and Questionnaires 7 Ipilimumab 7 linrodostat 5 Standard of Care 5 Paclitaxel 5 Bevacizumab 5 temsirolimus 4 Sirolimus 4 Interviews as Topic 4 Gemcitabine 4 Docetaxel 4 relatlimab 3 Vorinostat 3 Pemetrexed 3 Erlotinib Hydrochloride 3 Cetuximab 3 Carboplatin 3 ARRY-334543 3 regorafenib 2 apatinib 2 abemaciclib 2 Trastuzumab 2 Sorafenib 2 N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 Dasatinib 2 Cisplatin 2 Chlorogenic Acid 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01393990 2020-03-24

A Study of LY2228820 in Participants With Advanced Cancer

Eli Lilly and Company

Phase 1 Completed

89 enrolled 30 charts

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡